Saito, Osamu, Yasuhiro Ando, Eiji Kusano, and Yasushi Asano. Functional characterization of basolateral and luminal dopamine receptors in rabbit CCD. Am J Physiol Renal Physiol 281: F114-F122, 2001.-Previous studies reported the existence of both D 1-and D2-like receptors in the cortical collecting duct (CCD). However, especially with regard to natriuresis, it remains controversial. In the present study, rabbit CCD was perfused to characterize the receptor subtypes responsible for the tubular actions. Basolateral dopamine (DA) induced a dose-dependent depolarization of transepithelial voltage. Basolateral domperidone, a D 2-like receptor antagonist, abolished depolarization, whereas SKF-81297, a D 1-like receptor agonist, showed no significant change. In addition, bromocriptine, a D2-like receptor agonist, also caused depolarization, whereas SKF-81297, a D 1-like receptor agonist, did not depolarize significantly. Moreover, RBI-257, a D 4-specific antagonist, reversed the basolateral DA-induced depolarization. In contrast to the basolateral side, luminal DA caused depolarization via a D 1-like receptor; however the change was less than that for basolateral DA. For further evaluation, 22 Na ϩ flux (JNa) was measured to confirm the effect of DA on Na ϩ transport. Basolateral DA also caused a suppression of J Na, and this reaction was abolished by domperidone. These results suggested that the basolateral D2-like receptor is mainly responsible for the natriuretic action of DA in rabbit CCD. in vitro microperfusion; transepithelial voltage; dopamine receptor; sodium transport; cortical collecting duct DOPAMINE (DA) CAUSES NATRIURESIS in various mammals, such as dogs, rats, rabbits, and humans (11, 22, 24 ). An increase in glomerular filtration rate (GFR) is a definite factor in natriuresis. In addition, DA causes vasodilatation of the renal artery, and this is the major mechanism for increasing GFR. As an endogenous catecholamine, DA also has been shown to inhibit angiotensin II-induced mesangial cell contraction (8). A physiological role of DA in glomerular contractility is supported by the presence of dopaminergic nerve endings close to the vascular pole of the glomeruli and juxtaglomerular cells (9).
DOPAMINE (DA) CAUSES NATRIURESIS in various mammals, such as dogs, rats, rabbits, and humans (11, 22, 24) . An increase in glomerular filtration rate (GFR) is a definite factor in natriuresis. In addition, DA causes vasodilatation of the renal artery, and this is the major mechanism for increasing GFR. As an endogenous catecholamine, DA also has been shown to inhibit angiotensin II-induced mesangial cell contraction (8) . A physiological role of DA in glomerular contractility is supported by the presence of dopaminergic nerve endings close to the vascular pole of the glomeruli and juxtaglomerular cells (9) .
With regard to electrolyte metabolism, DA directly suppresses tubular sodium reabsorption with a resultant increase in fractional excretion of sodium by inhibiting the activity of Na ϩ -K ϩ -ATPase in several nephron segments and also by suppressing the apical Na ϩ /H ϩ exchange in the proximal tubule (6) . The first two subsegments of the proximal tubule, i.e., S1 and S2, produce DA from L-dopa by the action of aromatic L-amino-acid decarboxylase. Proximal convoluted tubule also secretes the DA to basolateral and luminal sides (7) . Thus the proximal convoluted tubule-derived DA can act as a paracrine factor at adjacent and more distal segments (37) . In the medullary thick ascending limb of the loop of Henle, dopamine-and cAMP-regulated phosphoprotein (DARPP-32) has been identified in the kidney of rat, mouse, and rabbit (23) . This is another line of evidence that DA, as an endogenous hormone, may regulate the distal nephron functions. Indeed, in the collecting ducts, DA has been reported to inhibit sodium reabsorption (15, 17) .
The dopamine receptor family is divided into two major groups with pharmacological and molecular character, the D 1 -like and D 2 -like dopamine receptors, respectively (34, 35 (18, 36) . All subtypes of the dopamine receptors are expressed in the kidney (14, 25, 31) . In the rat cortical collecting duct (CCD), the D 1 receptor has been detected by in situ hybridization or immunohistochemistry (27) . Also, Satoh, et al. (32) have shown that DA decreases Na ϩ -K ϩ -ATPase activity in the CCD and medullary thick ascending limb of the rat. On the other hand, physiological studies suggested the presence of the D 2 -like receptor in rat (39) and rabbit CCD (26, 40) . Thus there still is controversy concerning the dominant receptor subtype in this segment. In addition, the polarity of the dopamine receptor localization, i.e., basolateral or luminal side of the tubule, remains unexplored.
In the present study, rabbit CCD was perfused in vitro, and the response of transepithelial voltage (V t ) and Na ϩ transport (J Na ) to basolateral and luminal DA was examined to characterize the subtypes and localization of the DA receptors.
METHODS
In vitro microperfusion. Single CCDs were dissected from kidneys of anesthetized (intravenous pentobarbital sodium, 1 mg/kg) female Japanese White rabbits, weighing 1.5-2.5 kg and perfused in a Lucite bath chamber on the stage of an inverted microscope at 37°C using the methods described previously (2, 5) . To facilitate luminal perfusate exchange during each experiment, a polyethylene tube (PE-10; ClayAdams, Parsippany, NJ) was placed inside pipette B, which was connected to the tubular lumen for perfusion. The luminal perfusate flow rate was adjusted by hydrostatic pressure. Luminal perfusate exchange was performed manually by injecting perfusate into the polyethylene tube, washing out the preexisting medium in pipette B.
The composition of bath medium and isotonic luminal perfusate was as follows (in mM): 105 NaCl, 25 NaHCO 3, 10 sodium acetate, 2.3 Na2HPO4, 10 NaH2PO4, 5 KCl, 1.8 CaCl2, 1.0 MgSO4, 8.3 glucose, and 5 alanine (osmolality 300 mosmol/kgH2O).
Before use, all solutions were bubbled to equilibration at 37°C with a 95% O2-5% CO2 gas mixture to achieve a pH of ϳ7.40 and a PCO2 of ϳ40 Torr. Bath medium was continuously exchanged during the experiment at a flow rate of 25 ml/h by using a syringe pump (model STC-521, Terumo, Tokyo, Japan). To exchange bath medium, 2 ml of new bath medium, which was warmed to 37°C, were rapidly infused three times into the bath chamber through another set of syringe and polyethylene tubing. This maneuver was completed within 30 s. Luminal perfusates were also shielded in plastic syringes until use. The pH of the solutions was checked again each time just before use by a pH meter (model M-220, Corning, NY).
Experiments were started after perfusion of tubules for 60-90 min at 37°C to obtain a stable V t and to eliminate residual actions of endogenous arginine vasopressin (AVP; equilibration period) (4). To detect cell damage and perfusate leak, luminal perfusates contained 0.2 mg/ml FD&C green dye. Appearance of the tubular cells and dye leakage were continuously monitored under the microscope. Tubules with dye leakage or an increasing number of cells stained with the dye were discarded.
Measurement of V t. The voltage difference between two calomel cell electrodes connected by Ringer-agarose bridges to the bath medium and perfusate in pipette B, respectively, was continuously monitored by an electrometer (model MEZ-8201, Nihon Kohden, Tokyo, Japan) by using standard techniques and recorded on a chart (model R202, Rikadenki, Tokyo, Japan).
When V t (in mV) was exclusively measured, a high perfusion rate (ϳ30 nl/min) was chosen, and the perfused fluid was collected in a large-volume (ϳ10-l) pipette to avoid changes in perfusion rate and perfusion pressure that might affect Vt during exchange or collection of luminal perfusate. After the equilibration period, stability of the V t was confirmed by exchanging the luminal perfusate for that containing vehicle alone. Because Vt was significantly different from tubule to tubule (Ϫ5 to Ϫ30 mV), when appropriately adequate for comparison, the degree of depolarization (%Vt change) was calculated from the Vt at maximal depolarization (Vt dep, max) and the corresponding basal Vt (Vt, basal) as follows
Agonists and antagonists. DA agonists and antagonists exert various binding specificities to the D 1-and D2-like receptors (1, 19, 20, 25, 43) .
In the present study, we used SKF-81297, a D1 and D5 agonist, as a D1-like receptor agonist and SCH-23390, a D1 and D5 antagonist, as a D1-like receptor antagonist. With reference to the D2-like receptor, we chose bromocriptine, a D2-like receptor agonist (D2, D3, and, partially, a D4 agonist) and domperidone (D2, D3, and D4 antagonist) as a D2-like receptor antagonist, respectively (33, 34, 35, 38) . For further http://ajprenal.physiology.org/ confirmation of D2-like receptor subtype, a specific D4 receptor antagonist, RBI-257, was also used (19) . Their pharmacological profiles are shown in Table 1 . All these reagents were purchased from Sigma (St. Louis, MO).
Effect of DA on Na ϩ transport. In this series of experiments, 22 NaCl (DuPont, Wilmington, DE) was added to the luminal perfusate as a tracer. Lumen-to-bath Na ϩ efflux, JNa (peq ⅐ min Ϫ1 ⅐ mm tubule Ϫ1 ), was calculated from the disappearance rate of 22 Na ϩ from the luminal perfusate according to the following equations
where Vo is the collection rate (in nl/min); Vp and t are the volume of the constriction pipette and collection time, respectively; Ki and Ko are the concentrations of Na ϩ in the perfusate and collected fluid, respectively; and L is the length of the tubule, which was measured directly at the end of each experiment with the eyepiece reticule. The radioactivity of 22 Na ϩ was counted by using a liquid scintillation counter (Auto-Gamma 5650, Packard Japan, Tokyo, Japan).
After the equilibration period mentioned above, two or three collections were made (basal period). Then, in 10-15 min, when V t depolarization was stabilized after addition of DA, three collections were made (experimental period).
To detect the reverse leakage of the bath medium into the tubular lumen, 22 Na ϩ activity of the first one or two basal collections was counted immediately. If leakage was suggested by an unusually low count rate, compared with those in the previous time control experiments (30) , the experiment was discontinued, although leakage was not observed in the present series of experiments.
Statistics. Data are presented as means Ϯ SE. Unless specified otherwise, differences among groups were assessed (Table 1 ). In the presence of SCH-23390, which by itself did not change V t , the depolarization induced by DA was not significantly altered (28.7 Ϯ 8.2% at 100 nM, 49.3 Ϯ 9.3% at 10 M) (Figs. 3A and 4A ). On the other hand, the DA-induced depolarization was significantly suppressed in the presence of domperidone, which by itself did not alter the V t (1.2 Ϯ 0.5% at 100 nM, 20.8 Ϯ 4.2% at 10 M, n ϭ 5) (Figs. 3B and 4B ).
For further confirmation, agonist studies were performed. Basolateral SKF-81297 (10 M), which agonizes both the D 1 and D 5 receptors (Table 1) , induced no significant V t change (3.5 Ϯ 3.8% at 100 nM and 5.6 Ϯ 5.8% at 10 M) (Figs. 5A and 6), whereas 100 nM and 10 M basolateral bromocriptine, a D2-like receptor agonist (mainly of D 2 and D 3 and, partially, of D 4 ) ( Table 1) , caused a dose-dependent depolarization (21.7 Ϯ 5.8% at 100 nM and 33.5 Ϯ 5.1% at 10 M, n ϭ 6) (Figs. 5B and 6 ). These results demonstrated that basolateral DA causes depolarization of the V t not via a D 1 -like receptor but via a D 2 -like receptor.
As recent papers suggested the existence of a D 4 receptor in CCD (39, 40) , we performed further evaluation for the subtype of the basolateral D 2 -like receptor. DA was applied in the presence of basolateral RBI-257, a specific D4 receptor antagonist (19) . Basolateral RBI-257 (10 M) did not change the V t by itself, whereas it abolished the action of 100 nM and 10 M basolateral DA. After washing out of RBI-257, significant depolarization was observed with a 10 M basolateral DA rechallenge (100 nM DA with RBI-257, 2.2 Ϯ 0.4%; 10 M DA with RBI-257, 5.2 Ϯ 0.5%; 10 M basolateral DA rechallenge, 73.2 Ϯ 5.1%, respectively; n ϭ 5) (Fig. 7) .
Effect of luminal DA on V t . Next, we investigated whether luminal DA exerts an effect on V t . Because urinary concentration of DA is 10-100 times higher than that at the plasma level (41), we chose higher concentrations for luminal study. Although 1 M luminal DA did not cause a significant depolarization (0.2 Ϯ 2.5%; n ϭ 8), 10 and 100 M luminal DA depolarized V t significantly (14.6 Ϯ 6.5% at 10 M, 18.2 Ϯ 6.8% at 100 M, respectively, n ϭ 8) (Figs. 8 and 9 ). Pretreatment with 10 M luminal SCH-23390 did not change V t by itself (4.1 Ϯ 2.2%; n ϭ 4); however, it completely blocked the luminal DA-induced depolarization (5.6 Ϯ 3.7%; n ϭ 4) (Fig. 10A) . In contrast, 10 M luminal domperidone, which also did not affect V t by itself (0.2 Ϯ 1.2%; n ϭ 4), failed to suppress the luminal 
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DA-induced depolarization (37.5 Ϯ 4.9%; n ϭ 4) (Fig.  10B) . In good agreement with these antagonist studies, 10 M luminal SKF-81297 mimicked the effect of luminal DA, whereas 10 M luminal bromocriptine had no significant effect (37.7 Ϯ 6.3% with luminal SKF-81297, Ϫ8.3 Ϯ 7.5% with luminal bromocriptine; n ϭ 6) (Figs. 11 and 12) .
Thus, like basolateral DA, luminal DA also induced depolarization of the V t . However, the receptor subtype responsible for this action was not a D 2 -like receptor but a D 1 -like receptor. Besides the difference in receptor subtype, it was noted that the depolarization induced by luminal DA required 10,000 times higher concentrations (Ͼ10 M) than those for basolateral DA (Ͼ1 nM). Also, the depolarization itself was much smaller than that induced by basolateral DA. Namely, at 10 M, basolateral and luminal DA depolarized V t by 75 and 15%, respectively (Fig. 2 vs. Fig. 9) .
Effect of the DA function on Na ϩ transport. It is known that the V t in CCD primarily represents lumento-basolateral Na ϩ flux (16) . To explore the mechanism of basolateral DA-induced depolarization, we performed an Na ϩ flux study. In the presence of 100 nM and 10 M basolateral DA, J Na was significantly decreased (basal, 51.4 Ϯ 4.2; 100 nM, 44.9 Ϯ 3.2; 10 M, 32.0 Ϯ 2.9 peq ⅐ min Ϫ1 ⅐ mm tubule
Ϫ1
, respectively) (Fig.  13A) . Pretreatment with 10 M basolateral domperidone reversed the DA-induced suppression of J Na (basal, 49.2 Ϯ 3.8; domperidone alone, 48.5 Ϯ 1.6; 10 M DA with domperidone, 46.6 Ϯ 3.5 peq ⅐ min Ϫ1 ⅐ mm tubule Ϫ1 , respectively) (Fig. 13B ). In contrast, however, 100 M luminal DA caused no significant change in J Na despite significant depolarization of V t at 100 M (data not shown).
DISCUSSION
In rat CCD, the presence of a D 1 -like receptor has been reported (29, 42) , whereas some previous studies demonstrated D 2 -like receptor activity in the same segment of the rabbit and the rat (26, 39) . Also, in vivo studies suggested that D 2 -like receptors are responsible for natriuresis (12, 17) . Differences between animal species may be one of the reasons for the discrepancy. In addition, polarized localization of different DA receptors in the apical and basolateral side of the epithelium may exist, like AVP or PGE 2 (2, 3, 5, 13) , yielding conflicting results in the previous studies. Indeed, apical DA receptors have been reported in the proximal tubules (10) as well as in the collecting duct (28, 40) .
To characterize receptor subtypes of DA in the rabbit CCD, we thus applied DA not only from the basolateral side but also from the luminal side. It was considered that the DA receptor resides on both sides of the CCD epithelium. Namely, DA depolarized the V t not only when applied from the basolateral side but also from the luminal side of the CCD. Interestingly, however, the depolarization was mediated by distinct subtypes of the DA receptor. From the basolateral side, DA appeared to induce depolarization via a D 2 -like receptor. The D 2 -like receptor includes D 2 , D 3 , and D 4 receptor subtypes (34, 35) . Our basolateral agonist study showed that the D 2 -like receptor was dominant, and the basolateral antagonist study also confirmed this result. Moreover, the D 4 subtype seemed to be the major basolateral DA receptor (Fig. 7) . However, concerning D 2 -like receptor subtypes, these results seemed slightly discrepant because bromocriptine agonizes the D 2 -like receptor (mainly via D 2 and D 3 receptors), and the affinity of the D 2 and D 3 receptors is nearly 10-100 times higher than that of the D 4 recep- tor (Table 1) . However, DA itself also indicated a much lower affinity to the D 4 receptor than to the D 2 and D 3 receptors. Indeed, the affinity of DA to the D 4 receptor has been shown to be only 10 times higher than that of bromocriptine (33, 38) . In our results, RBI-251 showed complete inhibition of the effects of basolateral DA. Interestingly, RBI-251 is a D 4 -specific antagonist. If the D 2 or D 3 receptor existed mainly in the basolateral In contrast, the D 1 -like receptor is the major apical DA receptor. Because there is no adequate antagonist or agonist to distinguish D 1 and D 5 receptors available at present (25, 33, 38) , in this study we could not specify the subtype of the D 1 -like receptor on the apical side.
In rat CCD, only D 3 and D 4 receptor subtypes have been demonstrated by in situ hybridization studies (28, 40) . The D 3 receptor resides exclusively on the apical side (28) , whereas D 4 receptor immunostaining was found on both sides of the epithelia (40) . These discrepancies between rat and rabbit argue for the species difference in DA receptor subtype in the CCD.
With respect to the role of basolateral and luminal DA receptors in Na ϩ transport, the present study demonstrated that basolateral DA receptors are primarily responsible for the inhibition of Na ϩ transport. Although luminal DA caused modest depolarization at concentrations Ͼ10 M (Fig. 9) , it failed to cause a significant suppression of Na ϩ transport (data not shown). Thus the mechanism of depolarization induced by luminal DA remains unknown. However, a similar Na ϩ -independent change in V t has been noted in rabbit CCD when AVP is applied from the luminal side (5). Luminal AVP has been shown to suppress H ϩ secretion in this segment (21) . Therefore, luminal DA may depolarize the V t by modulating electrogenic transport other than that of Na ϩ . Further studies are needed to evaluate the regulation between basolateral and luminal DA. 
